Author:
Lee Ji-Hyun,Baik Jong-Min,Yu Young-Soo,Kim Joo Hyun,Ahn Chi Bum,Son Kuk Hui,Kim Joo-Hyung,Choi Eun Seok,Lee Jin Woo
Abstract
AbstractIn general, osteomyelitis is treated with antibiotics, and in severe cases, the inflammatory bone tissue is removed and substituted with poly (methyl methacrylate) (PMMA) beads containing antibiotics. However, this treatment necessitates re-surgery to remove the inserted PMMA beads. Moreover, rifampicin, a primary heat-sensitive antibiotic used for osteomyelitis, is deemed unsuitable in this strategy. Three-dimensional (3D) printing technology has gained popularity, as it facilitates the production of a patient-customized implantable structure using various biodegradable biomaterials as well as controlling printing temperature. Therefore, in this study, we developed a rifampicin-loaded 3D scaffold for the treatment of osteomyelitis using 3D printing and polycaprolactone (PCL), a biodegradable polymer that can be printed at low temperatures. We successfully fabricated rifampicin-loaded PCL 3D scaffolds connected with all pores using computer-aided design and manufacturing (CAD/CAM) and printed them at a temperature of 60 °C to prevent the loss of the antibacterial activity of rifampicin. The growth inhibitory activity against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), the representative causative organisms of osteomyelitis, was confirmed. In addition, we optimized the rifampicin-loading capacity that causes no damage to the normal bone tissues in 3D scaffold with toxicity evaluation using human osteoblasts. The rifampicin-releasing 3D scaffold developed herein opens new possibilities of the patient-customized treatment of osteomyelitis.
Funder
Korea Health Industry Development Institute
Gil Medical Center, Gachon University
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Chen, P. et al. Differentially expressed genes in osteomyelitis induced by Staphylococcus aureus infection. Front. Microbiol. 9, 1093 (2018).
2. Carek, P. J., Dickerson, L. M. & Sack, J. L. Diagnosis and management of osteomyelitis. Am. Fam. Physician. 63, 2413–2420 (2001).
3. Gaynes, R. The discovery of penicillin - new insights after more than 75 years of clinical use. Emerg. Infect. Dis. 23, 849–853 (2017).
4. Henry, F. C. & Frank, R. D. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629–641 (2009).
5. Harkins, C. P. et al. Genome Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. 18, 130 (2017).
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献